Literature DB >> 31751117

Multilayered N-Glycoproteome Profiling Reveals Highly Heterogeneous and Dysregulated Protein N-Glycosylation Related to Alzheimer's Disease.

Pan Fang1, JuanJuan Xie1, Shaoming Sang2, Lei Zhang1, Mingqi Liu1, Lujie Yang1, Yiteng Xu1, Guoquan Yan1, Jun Yao1, Xing Gao1, Wenjing Qian2, Zhongfeng Wang2, Yang Zhang1, Pengyuan Yang1,3,4, Huali Shen1,4.   

Abstract

Protein N-glycosylation is ubiquitous in the brain and is closely related to cognition and memory. Alzheimer's disease (AD) is a multifactorial disorder that lacks a clear pathogenesis and treatment. Aberrant N-glycosylation has been suggested to be involved in AD pathology. However, the systematic variations in protein N-glycosylation and their roles in AD have not been thoroughly investigated due to technical challenges. Here, we applied multilayered N-glycoproteomics to quantify the global protein expression levels, N-glycosylation sites, N-glycans, and site-specific N-glycopeptides in AD (APP/PS1 transgenic) and wild-type mouse brains. The N-glycoproteomic landscape exhibited highly complex site-specific heterogeneity in AD mouse brains. The generally dysregulated N-glycosylation in AD, which involved proteins such as glutamate receptors as well as fucosylated and oligomannose glycans, were explored by quantitative analyses. Furthermore, functional studies revealed the crucial effects of N-glycosylation on proteins and neurons. Our work provides a systematic multilayered N-glycoproteomic strategy for AD and can be applied to diverse biological systems.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31751117     DOI: 10.1021/acs.analchem.9b03555

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  14 in total

1.  Glycomic profiling and the mammalian brain.

Authors:  Jennyfer Tena; Carlito B Lebrilla
Journal:  Proc Natl Acad Sci U S A       Date:  2021-01-05       Impact factor: 11.205

Review 2.  Injectable biomaterial shuttles for cell therapy in stroke.

Authors:  Juhi Samal; Tatiana Segura
Journal:  Brain Res Bull       Date:  2021-08-12       Impact factor: 3.715

3.  Optimal Dissociation Methods Differ for N- and O-Glycopeptides.

Authors:  Nicholas M Riley; Stacy A Malaker; Marc D Driessen; Carolyn R Bertozzi
Journal:  J Proteome Res       Date:  2020-06-28       Impact factor: 4.466

Review 4.  Towards structure-focused glycoproteomics.

Authors:  Anastasia Chernykh; Rebeca Kawahara; Morten Thaysen-Andersen
Journal:  Biochem Soc Trans       Date:  2021-02-26       Impact factor: 5.407

5.  Precision N-Glycoproteomic Profiling of Murine Peritoneal Macrophages After Different Stimulations.

Authors:  Lujie Yang; Tianqi Gong; Huali Shen; Jiangnan Pei; Lei Zhang; Quanqing Zhang; Yuanyu Huang; Zuojian Hu; Ziyue Pan; Pengyuan Yang; Ling Lin; Hongxiu Yu
Journal:  Front Immunol       Date:  2021-08-17       Impact factor: 7.561

6.  Integrative glycoproteomics reveals protein N-glycosylation aberrations and glycoproteomic network alterations in Alzheimer's disease.

Authors:  Qi Zhang; Cheng Ma; Lih-Shen Chin; Lian Li
Journal:  Sci Adv       Date:  2020-10-02       Impact factor: 14.136

7.  Towards Mapping of the Human Brain N-Glycome with Standardized Graphitic Carbon Chromatography.

Authors:  Johannes Helm; Lena Hirtler; Friedrich Altmann
Journal:  Biomolecules       Date:  2022-01-06

8.  Recent Advances in Software Tools for More Generic and Precise Intact Glycopeptide Analysis.

Authors:  Weiqian Cao; Mingqi Liu; Siyuan Kong; Mengxi Wu; Yang Zhang; Pengyuan Yang
Journal:  Mol Cell Proteomics       Date:  2021-02-06       Impact factor: 5.911

Review 9.  A Pragmatic Guide to Enrichment Strategies for Mass Spectrometry-Based Glycoproteomics.

Authors:  Nicholas M Riley; Carolyn R Bertozzi; Sharon J Pitteri
Journal:  Mol Cell Proteomics       Date:  2020-12-20       Impact factor: 5.911

Review 10.  The Hitchhiker's guide to glycoproteomics.

Authors:  Tiago Oliveira; Morten Thaysen-Andersen; Nicolle H Packer; Daniel Kolarich
Journal:  Biochem Soc Trans       Date:  2021-08-27       Impact factor: 5.407

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.